In pharmaceutical manufacturing, temperature is not simply a process parameter, it is a critical component of product quality and regulatory compliance.
Processes such as drying, sterilisation, reactor heating and clean-in-place (CIP) systems rely on tightly controlled thermal conditions to ensure that every batch meets defined specifications. These processes are often validated, meaning they must operate consistently and predictably every time.
Any variation in thermal performance can have serious consequences. Unlike many other industries, where variability may lead to scrap or rework, in pharmaceutical production it can result in:
For this reason, maintaining stable, repeatable and fully traceable heating performance is essential.
Pharmaceutical processes are highly sensitive to temperature because they often involve:
Each of these processes depends on achieving and maintaining precise thermal conditions.
In drying applications such as fluid bed dryers or tray dryers, temperature influences how moisture is removed from the product. Variations can lead to inconsistent residual moisture levels, affecting product stability and shelf life.
In sterilisation processes, insufficient temperature or exposure time may compromise sterility, while excessive heating can degrade the product.
Because these processes are validated, consistency is not optional, it is a requirement.
In pharmaceutical manufacturing, variability is not just a quality issue, it is a compliance issue.
Any deviation from expected process conditions must be investigated and documented. This creates additional workload, delays production and may require batch quarantine or rejection.
Inconsistent thermal performance can therefore lead to:
Maintaining stable heating conditions helps minimise variability and reduces the risk of compliance-related issues.
Temperature control systems regulate process conditions based on feedback from sensors. However, achieving repeatable performance also depends on how energy is delivered to the heating system.
If power is applied unevenly or in large steps, it can introduce small fluctuations in heat input. In sensitive pharmaceutical processes, these fluctuations can affect how the system responds, particularly during critical phases such as ramp-up or hold periods.
More controlled and proportional power delivery allows heat to be applied smoothly, supporting stable and repeatable process conditions.
This is particularly important in validated processes where reproducibility is essential.
Pharmaceutical equipment typically uses electrically heated systems in applications such as:
These systems often use resistive heating elements, which require stable and controlled power delivery to maintain consistent performance.
In many cases, burst firing control provides effective and efficient regulation of resistive loads. However, the key requirement is not just control, but repeatability and stability over time.
In pharmaceutical production, unplanned downtime carries additional consequences compared to many other industries.
If a heating system fails during a batch process, the batch may need to be discarded, depending on the stage of production and regulatory requirements.
One common source of failure in heating systems is the use of mechanical contactors. These devices are subject to wear due to repeated switching and electrical arcing.
Over time, this can lead to unreliable operation, resulting in:
Modern power control systems eliminate these mechanical wear points and provide greater reliability.
In addition, early fault detection allows issues such as heater failure to be identified before they affect the process, enabling proactive maintenance and reducing the risk of batch disruption.
A key requirement in pharmaceutical manufacturing is the ability to demonstrate that processes are controlled and repeatable.
This requires not only stable operation, but also the ability to record and review process data.
Modern power controllers provide data logging and operational visibility, allowing heating performance to be monitored and recorded alongside process parameters.
This supports:
Having access to historical data makes it easier to identify trends, understand process behaviour and demonstrate compliance with regulatory requirements.
In many pharmaceutical environments, access to equipment may be restricted due to cleanliness or containment requirements. Being able to monitor system performance without opening panels or interrupting operation is therefore highly valuable.
Modern systems provide remote access to live data, allowing engineers to view heating performance via secure interfaces, including mobile devices. This improves response time, supports troubleshooting and reduces the need for physical intervention.
Pharmaceutical processes are typically managed through integrated control systems.
Power controllers that support communication protocols such as Profibus and Profinet can be integrated with PLC and SCADA systems, allowing heating performance and alarms to be monitored centrally.
This improves visibility, simplifies operation and ensures that heating systems are fully aligned with the overall process control strategy.
Integration also supports traceability, ensuring that all relevant data is available for review and compliance purposes.
By improving how electrical power is delivered and monitored, pharmaceutical manufacturers can achieve more stable and reliable thermal processes.
This supports:
In regulated environments, these benefits contribute directly to both operational efficiency and product integrity.
In pharmaceutical processes, selecting a power control solution is not just about temperature control, it is about ensuring stability, repeatability and compliance.
The system must support consistent heat delivery, provide clear diagnostic information and integrate seamlessly with plant control systems.
CD Automation’s range of thyristor power controllers, including REVO S and REVO C, are designed for applications requiring precise and reliable control of electrical heating.
With features such as proportional power control, early fault detection, data logging, remote access and industrial communication support, these systems help pharmaceutical manufacturers maintain control over both process performance and compliance requirements.
If your pharmaceutical process requires improved stability, repeatability or visibility of heating performance, CD Automation can support you in selecting the most appropriate power control solution.
Further application information can be found on our Pharmaceutical, Biotech & Fine Chemical Production page.
Or contact our engineering team to assess your current heating control strategy.
Click the link in the page footer below to ‘Book a telephone callback’, or click the ‘Contact Us' button to request a no-obligation quotation, or simply ask a question. We're here to help.
